Press Release
« Back
Celldex Therapeutics Announces Upcoming Presentation at the Credit Suisse 2013 Antibody Day
May 6, 2013
A live webcast of the presentation will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available for 30 days following the event.
About
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit http://www.celldextherapeutics.com.
CONTACT:Source:Sarah Cavanaugh Vice President of Investor Relations& Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 scavanaugh@celldextherapeutics.com
News Provided by Acquire Media